Verrica Pharmaceuticals Inc (VRCA)
7.22
+0.17
(+2.41%)
USD |
NASDAQ |
Jun 27, 16:00
7.22
0.00 (0.00%)
After-Hours: 20:00
Verrica Pharmaceuticals Free Cash Flow: -53.93M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -53.93M |
| December 31, 2023 | -38.94M |
| September 30, 2023 | -29.22M |
| June 30, 2023 | -12.60M |
| March 31, 2023 | -15.21M |
| December 31, 2022 | -18.95M |
| September 30, 2022 | -22.87M |
| June 30, 2022 | -35.25M |
| March 31, 2022 | -25.71M |
| December 31, 2021 | -28.46M |
| September 30, 2021 | -26.17M |
| June 30, 2021 | -23.26M |
| March 31, 2021 | -34.17M |
| Date | Value |
|---|---|
| December 31, 2020 | -31.68M |
| September 30, 2020 | -33.25M |
| June 30, 2020 | -33.44M |
| March 31, 2020 | -29.78M |
| December 31, 2019 | -28.09M |
| September 30, 2019 | -27.43M |
| June 30, 2019 | -24.67M |
| March 31, 2019 | -23.39M |
| December 31, 2018 | -18.65M |
| September 30, 2018 | -12.82M |
| June 30, 2018 | -8.756M |
| March 31, 2018 | -6.228M |
| December 31, 2017 | -4.583M |
Free Cash Flow Range, Past 5 Years
-53.93M
Minimum
Mar 2024
-12.60M
Maximum
Jun 2023
-28.65M
Average
-28.28M
Median
Free Cash Flow Benchmarks
| Emergent BioSolutions Inc | -132.20M |
| Macrogenics Inc | -113.88M |
| Aquestive Therapeutics Inc | -26.60M |
| Recursion Pharmaceuticals Inc | -330.63M |
| Omega Therapeutics Inc | -78.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.95M |
| Cash from Financing (Quarterly) | -0.661M |
| Free Cash Flow Per Share (Quarterly) | -0.4291 |
| Free Cash Flow to Equity (Quarterly) | -19.92M |
| Free Cash Flow Yield | -16.17% |